Abstract
Abstract
Endoscopic ultrasound‐guided radiofrequency ablation (EUS‐RFA) is an emerging technique for treating pancreatic and neuroendocrine tumors in patients who are not candidates for surgery. However, there is limited evidence of EUS‐RFA in hepatic cancers. The present case series describes five elderly patients with compensated cirrhotic hepatocellular carcinomas (HCCs) treated locally using EUS‐RFA. Alpha‐fetoprotein levels were reduced in patients after 1 month of the procedure. Computed tomography analysis also reported a reduction in HCCs in patients postoperatively. Repeat computed tomography triple‐phase abdomen also showed complete radiological response to treatment in lesions <3 cm. None of the patients reported any procedural adverse event. EUS‐RFA offers safe ablation of <3 cm HCC lesions.